Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan · Delayed Price · Currency is TWD 88.70
+0.60 (0.68%)
Jun 3, 2026, 1:52 PM CST
Puriblood Medical Market Cap
Puriblood Medical has a market cap or net worth of 1.26 billion as of June 3, 2026. Its market cap has increased by 10.32% in one year.
Market Cap
1.26B
Enterprise Value
1.25B
Revenue
82.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
88.70
Market Cap Chart
Since November 5, 2021, Puriblood Medical's market cap has decreased from 1.83B to 1.26B, a decrease of -30.97%. That is a compound annual growth rate of -7.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 1.26B | 23.19% |
| Dec 31, 2025 | 1.02B | -28.36% |
| Dec 31, 2024 | 1.43B | -10.67% |
| Dec 29, 2023 | 1.60B | -16.97% |
| Dec 27, 2022 | 1.93B | -16.36% |
| Dec 30, 2021 | 2.31B | 26.07% |
| Nov 5, 2021 | 1.83B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.36B |
| DIVA Laboratories | 1.87B |
| Genetics Generation Advancement | 1.08B |
| TFBS Bioscience | 714.51M |
| Kim Forest Enterprise | 709.30M |
| Sofiva Genomics | 708.26M |
| Pharmigene | 439.05M |
| Welgene Biotech | 386.85M |